Health and wellbeing

Elsevier,

Forensic Science International: Mind and Law, Volume 2, November 2021

A look at forensic psychiatry in Africa and how it's developed.
Elsevier,

Public Health in Practice, Volume 2, November 2021

Assessment of mental health in Nigeria and how it compares to the rest of Africa and the world.
This book chapter advances SDGs 3 and 17 by outlining the common physical impairments found in people living with dementia, as well as evidence for treatments to maintain or improve physical function and prevent falls, in both community and residential settings.
Elsevier,

Current Opinion in Chemical Biology, Volume 64, October 2021

A review of potential inhibitors of amyloid protein aggregation, one of the causes of neurodegredation.
Elsevier,

Prostaglandins and Other Lipid Mediators, Volume 156, October 2021

This review focuses on the role of 7-ketocholesterol (7KCh) mediated neurodegenerative Alzheimer’s disease with emphasis on alterations in the lipid raft microdomain. In addition, current trends in the significant therapies related to 7KCh inhibition are highlighted.
An evaluation of the pharmacological potency of 2 agents which may lead to the development of treatment for Alzheimer's.
Elsevier,

Current Opinion in Chemical Biology, Volume 64, October 2021

A review of peptide model systems used to investigate and understand the structures, biological properties, and biophysical properties of amyloid oligomers linked to diseases such as Alzheimers.
A review of recent advances in protein chemistry, biophysics, advanced imaging, and proteomics and the way they could be applied to decipher and embrace the complexity of protein aggregation and pathology formation. This may advance translational research and drug discovery in neurodegenerative diseases.
Multiple factors such genetics, metabolism, and lifestyle factors are involved in both COVID-19 and Alzheimer’s disease.

Pages